Seer Inc Overview
Pro stress-test →Seer Inc is a life sciences company that develops and commercializes the Proteograph Product Suite, an integrated solution including proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis. The company enables researchers to decode biology at the protein level, addressing a critical gap in precision medicine research.
Strategic Profile
Pro stress-test →Seer markets its products for research use only to academic institutions, life sciences and research laboratories, and biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company has validated its Proteograph product suite for population-scale, peptide-level mass spectrometry proteomics through a Nature Genetics study, strengthening its competitive positioning in the emerging proteomics space.
Competitive Landscape
Pro stress-test →Seer competes in the emerging proteomics market against established life science tool providers (Thermo Fisher, Waters Corporation) and specialized proteomics companies. Seer's differentiation lies in its proprietary nanoparticle technology enabling rapid, unbiased protein detection at scale. Competition intensifies as major instrument manufacturers expand proteomics offerings.
Industry Context
Seer Inc operates in Life Sciences / Proteomics Technology.
Key facts
Founded: 2017 · Headquarters: Redwood City, California · Revenue: $4.1M (Q3 2025) · Market cap: $136M